Hm Payson & CO Abiomed Inc Transaction History

Hm Payson & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$300.63 - $371.35 $9,319 - $11,511	-31 Reduced 10.8%	256 $92,000
Q3 2021 Nov 30, 2021	SELL	$310.19 - $376.2 $11,166 - $13,543	-36 Reduced 11.15%	287 $93,000
Q2 2021 Aug 17, 2021	SELL	$262.71 - $351.17 $48,075 - $64,264	-183 Reduced 36.17%	323 $101,000
Q1 2021 Jun 15, 2021	BUY	$285.92 - $355.13 $142,960 - $177,565	500 Added 8333.33%	506 $161,000
Q3 2020 Dec 21, 2020	BUY	$255.22 - $317.0 $1,531 - $1,902	6 New	6 $2,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

Stay updated on Hm Payson & CO with notifications on news.